Tempest Therapeutics, Inc. (TPST) financial statements and ratios from SEC XBRL: revenue $295000.00 (TTM), net margin -17279.7%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $295000.00 |
| Net Margin | -17279.7% |
| Return on Equity | 3713.0% |
| Debt / Equity | -3.85 |
| Current Ratio | 0.38 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -99.6% |
| FCF Growth (YoY) | 16.4% |
| EV / EBITDA | -0.5 |
| Price / Book | -15.69 |
| FCF Yield | -121.2% |
TPST overview · TPST earnings · TPST KPIs · TPST investor relations · TPST ownership · TPST peers · TPST filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.